---
title: Filler Safety Recommendations,  Billing CPT Codes and More | April LiVDerm Newsletter
---

FDA Grants Orphan Drug Designation to LNS8801 for Metastatic Uveal Melanoma...

| View in browser APRIL       Industry Updates Dermatology Times FDA Grants Orphan Drug Designation to LNS8801 for Metastatic Uveal Melanoma   MDEdge New analysis examines the surgical landscape for hidradenitis suppurativa   Dermatology Times AMA Streamlines Billing CPT Codes   MDEdge ASDS issues first filler safety recommendations   Healio Retrospective study demonstrates potassium monitoring remains common in women treated for acne with spironolactone   Practice Update Safety of Low-Dose Oral Minoxidil for Hair Loss         Coming Soon                   Featured Resource Curious about what takes place at LiVDerm events? Check out our featured highlights to review our highly acclaimed conferences.       Best Blog READ MORE       LiVDerm, 1801 N Military Trl Ste 200, Boca Raton, FL 33431-1810, United States, 561-893-8625 Unsubscribe Manage preferences |
| --- |